Cargando…

Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial

BACKGROUND: Hypertension is one of the key factors causing cardiovascular diseases. A substantial proportion of treated hypertensive patients do not reach recommended target blood pressure values. Shared decision making (SDM) is to enhance the active role of patients. As until now there exists littl...

Descripción completa

Detalles Bibliográficos
Autores principales: Tinsel, Iris, Buchholz, Anika, Vach, Werner, Siegel, Achim, Dürk, Thorsten, Buchholz, Angela, Niebling, Wilhelm, Fischer, Karl-Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847233/
https://www.ncbi.nlm.nih.gov/pubmed/24024587
http://dx.doi.org/10.1186/1471-2296-14-135
_version_ 1782293570179301376
author Tinsel, Iris
Buchholz, Anika
Vach, Werner
Siegel, Achim
Dürk, Thorsten
Buchholz, Angela
Niebling, Wilhelm
Fischer, Karl-Georg
author_facet Tinsel, Iris
Buchholz, Anika
Vach, Werner
Siegel, Achim
Dürk, Thorsten
Buchholz, Angela
Niebling, Wilhelm
Fischer, Karl-Georg
author_sort Tinsel, Iris
collection PubMed
description BACKGROUND: Hypertension is one of the key factors causing cardiovascular diseases. A substantial proportion of treated hypertensive patients do not reach recommended target blood pressure values. Shared decision making (SDM) is to enhance the active role of patients. As until now there exists little information on the effects of SDM training in antihypertensive therapy, we tested the effect of an SDM training programme for general practitioners (GPs). Our hypotheses are that this SDM training (1) enhances the participation of patients and (2) leads to an enhanced decrease in blood pressure (BP) values, compared to patients receiving usual care without prior SDM training for GPs. METHODS: The study was conducted as a cluster randomised controlled trial (cRCT) with GP practices in Southwest Germany. Each GP practice included patients with treated but uncontrolled hypertension and/or with relevant comorbidity. After baseline assessment (T0) GP practices were randomly allocated into an intervention and a control arm. GPs of the intervention group took part in the SDM training. GPs of the control group treated their patients as usual. The intervention was blinded to the patients. Primary endpoints on patient level were (1) change of patients’ perceived participation (SDM-Q-9) and (2) change of systolic BP (24h-mean). Secondary endpoints were changes of (1) diastolic BP (24h-mean), (2) patients’ knowledge about hypertension, (3) adherence (MARS-D), and (4) cardiovascular risk score (CVR). RESULTS: In total 1357 patients from 36 general practices were screened for blood pressure control by ambulatory blood pressure monitoring (ABPM). Thereof 1120 patients remained in the study because of uncontrolled (but treated) hypertension and/or a relevant comorbidity. At T0 the intervention group involved 17 GP practices with 552 patients and the control group 19 GP practices with 568 patients. The effectiveness analysis could not demonstrate a significant or relevant effect of the SDM training on any of the endpoints. CONCLUSION: The study hypothesis that the SDM training enhanced patients’ perceived participation and lowered their BP could not be confirmed. Further research is needed to examine the impact of patient participation on the treatment of hypertension in primary care. TRIAL REGISTRATION: German Clinical Trials Register (DRKS): DRKS00000125
format Online
Article
Text
id pubmed-3847233
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38472332013-12-04 Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial Tinsel, Iris Buchholz, Anika Vach, Werner Siegel, Achim Dürk, Thorsten Buchholz, Angela Niebling, Wilhelm Fischer, Karl-Georg BMC Fam Pract Research Article BACKGROUND: Hypertension is one of the key factors causing cardiovascular diseases. A substantial proportion of treated hypertensive patients do not reach recommended target blood pressure values. Shared decision making (SDM) is to enhance the active role of patients. As until now there exists little information on the effects of SDM training in antihypertensive therapy, we tested the effect of an SDM training programme for general practitioners (GPs). Our hypotheses are that this SDM training (1) enhances the participation of patients and (2) leads to an enhanced decrease in blood pressure (BP) values, compared to patients receiving usual care without prior SDM training for GPs. METHODS: The study was conducted as a cluster randomised controlled trial (cRCT) with GP practices in Southwest Germany. Each GP practice included patients with treated but uncontrolled hypertension and/or with relevant comorbidity. After baseline assessment (T0) GP practices were randomly allocated into an intervention and a control arm. GPs of the intervention group took part in the SDM training. GPs of the control group treated their patients as usual. The intervention was blinded to the patients. Primary endpoints on patient level were (1) change of patients’ perceived participation (SDM-Q-9) and (2) change of systolic BP (24h-mean). Secondary endpoints were changes of (1) diastolic BP (24h-mean), (2) patients’ knowledge about hypertension, (3) adherence (MARS-D), and (4) cardiovascular risk score (CVR). RESULTS: In total 1357 patients from 36 general practices were screened for blood pressure control by ambulatory blood pressure monitoring (ABPM). Thereof 1120 patients remained in the study because of uncontrolled (but treated) hypertension and/or a relevant comorbidity. At T0 the intervention group involved 17 GP practices with 552 patients and the control group 19 GP practices with 568 patients. The effectiveness analysis could not demonstrate a significant or relevant effect of the SDM training on any of the endpoints. CONCLUSION: The study hypothesis that the SDM training enhanced patients’ perceived participation and lowered their BP could not be confirmed. Further research is needed to examine the impact of patient participation on the treatment of hypertension in primary care. TRIAL REGISTRATION: German Clinical Trials Register (DRKS): DRKS00000125 BioMed Central 2013-09-11 /pmc/articles/PMC3847233/ /pubmed/24024587 http://dx.doi.org/10.1186/1471-2296-14-135 Text en Copyright © 2013 Tinsel et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tinsel, Iris
Buchholz, Anika
Vach, Werner
Siegel, Achim
Dürk, Thorsten
Buchholz, Angela
Niebling, Wilhelm
Fischer, Karl-Georg
Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial
title Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial
title_full Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial
title_fullStr Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial
title_full_unstemmed Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial
title_short Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial
title_sort shared decision-making in antihypertensive therapy: a cluster randomised controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847233/
https://www.ncbi.nlm.nih.gov/pubmed/24024587
http://dx.doi.org/10.1186/1471-2296-14-135
work_keys_str_mv AT tinseliris shareddecisionmakinginantihypertensivetherapyaclusterrandomisedcontrolledtrial
AT buchholzanika shareddecisionmakinginantihypertensivetherapyaclusterrandomisedcontrolledtrial
AT vachwerner shareddecisionmakinginantihypertensivetherapyaclusterrandomisedcontrolledtrial
AT siegelachim shareddecisionmakinginantihypertensivetherapyaclusterrandomisedcontrolledtrial
AT durkthorsten shareddecisionmakinginantihypertensivetherapyaclusterrandomisedcontrolledtrial
AT buchholzangela shareddecisionmakinginantihypertensivetherapyaclusterrandomisedcontrolledtrial
AT nieblingwilhelm shareddecisionmakinginantihypertensivetherapyaclusterrandomisedcontrolledtrial
AT fischerkarlgeorg shareddecisionmakinginantihypertensivetherapyaclusterrandomisedcontrolledtrial